WIEDEMANN, A.; FOUCAT, E.; HOCINI, H.; LEFEBVRE, C.; HEJBLUM, Boris; DURAND, Melany; KRUGER, Miriam; KEITA, A. K.; AYOUBA, A.; MÉLY, S.; FERNANDEZ, J. C.; TOURÉ, A.; FOURATI, S.; LÉVY-MARCHAL, C.; RAOUL, H.; DELAPORTE, E.; KOIVOGUI, L.; THIEBAUT, Rodolphe; LACABARATZ, C.; LEVY, Y.

doi:10.1038/s41467-020-17489-7

Langue

Article de revue

Ce document a été publié dans

Nature Communications. 2020, vol. 11, n° 1, p. 3730

Résumé en anglais

Long-term follow up studies from Ebola virus disease (EVD) survivors (EBOV_S) are lacking. Here, we evaluate immune and gene expression profiles in 35 Guinean EBOV_S from the last West African outbreak, a median of 23 months (IQR [18–25]) after discharge from treatment center. Compared with healthy donors, EBOV_S exhibit increases of blood markers of inflammation, intestinal tissue damage, T cell and B cell activation and a depletion of circulating dendritic cells. All survivors have EBOV-specific IgG antibodies and robust and polyfunctional EBOV-specific memory T-cell responses. Deep sequencing of the genes expressed in blood reveals an enrichment in ‘inflammation’ and ‘antiviral’ pathways. Integrated analyses identify specific immune markers associated with the persistence of clinical symptoms. This study identifies a set of biological and genetic markers that could be used to define a signature of “chronic Ebola virus disease (CEVD)”.< Réduire

Mots clés

SISTM

URI

https://oskar-bordeaux.fr/handle/20.500.12278/26320

DOI

http://dx.doi.org/10.1038/s41467-020-17489-7

Unités de recherche

Bordeaux Population Health Research Center (BPH) - UMR 1219

Voir/Ouvrir

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Long-lasting severe immune dysfunction in Ebola virus disease survivors

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés

URI

DOI

Unités de recherche